PULMONX CORPORATION Cash and Restricted Cash
PULMONX CORPORATION (LUNG) had Cash and Restricted Cash of $56.10 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $56.10M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $61.83M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $70.01M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $76.81M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $56.10M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $61.83M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $70.01M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $76.81M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $75.72M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $74.81M 10-Q · filed 2026-05-04 |
| 2024-12-31 | $71.16M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $63.57M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $63.72M 10-Q · filed 2025-08-01 |
| 2024-03-31 | $70.39M 10-Q · filed 2025-05-02 |
| 2023-12-31 | $83.78M 10-K · filed 2026-03-10 |
| 2023-09-30 | $95.18M 10-Q · filed 2024-11-01 |
| 2023-06-30 | $102.05M 10-Q · filed 2024-08-02 |
| 2023-03-31 | $110.64M 10-Q · filed 2024-05-03 |
| 2022-12-31 | $101.97M 10-K · filed 2025-02-25 |
| 2022-09-30 | $112.63M 10-Q · filed 2023-11-03 |
| 2022-06-30 | $122.18M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $129.40M 10-Q · filed 2023-05-08 |
| 2021-12-31 | $148.71M 10-K · filed 2024-02-27 |
| 2021-09-30 | $188.31M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $198.93M 10-Q · filed 2022-08-08 |
| 2021-03-31 | $209.51M 10-Q · filed 2022-05-09 |
| 2020-12-31 | $231.79M 10-K · filed 2023-03-01 |
| 2020-09-30 | $40.04M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $43.58M 10-Q · filed 2021-08-10 |
| 2020-03-31 | $16.47M 10-Q · filed 2021-05-12 |
| 2019-12-31 | $14.77M 10-K · filed 2022-03-01 |
| 2019-09-30 | $15.73M 10-Q · filed 2020-11-13 |
| 2018-12-31 | $4.12M 10-K · filed 2021-03-15 |
| 2017-12-31 | $10.05M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |